Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1991 2
1992 3
1993 5
1994 10
1995 3
1996 13
1997 10
1998 3
1999 7
2000 7
2001 8
2002 10
2003 9
2004 15
2005 15
2006 17
2007 16
2008 10
2009 10
2010 14
2011 18
2012 14
2013 16
2014 17
2015 8
2016 16
2017 12
2018 21
2019 17
2020 22
2021 20
2022 8
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
Psoriasis.
Boehncke WH, Schön MP. Boehncke WH, et al. Lancet. 2015 Sep 5;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7. Epub 2015 May 27. Lancet. 2015. PMID: 26025581 Review.
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M, Primdahl J, McGonagle DG, Aletaha D, Balanescu A, Balint PV, Bertheussen H, Boehncke WH, Burmester GR, Canete JD, Damjanov NS, Kragstrup TW, Kvien TK, Landewé RBM, Lories RJU, Marzo-Ortega H, Poddubnyy D, Rodrigues Manica SA, Schett G, Veale DJ, Van den Bosch FE, van der Heijde D, Smolen JS. Gossec L, et al. Among authors: boehncke wh. Ann Rheum Dis. 2020 Jun;79(6):700-712. doi: 10.1136/annrheumdis-2020-217159. Ann Rheum Dis. 2020. PMID: 32434812 Free PMC article.
IL-25 (IL-17E) in epithelial immunology and pathophysiology.
Borowczyk J, Shutova M, Brembilla NC, Boehncke WH. Borowczyk J, et al. Among authors: boehncke wh. J Allergy Clin Immunol. 2021 Jul;148(1):40-52. doi: 10.1016/j.jaci.2020.12.628. Epub 2021 Jan 20. J Allergy Clin Immunol. 2021. PMID: 33485651 Review.
La dermatologie à l’ère du Covid-19.
Gilliet M, Boehncke WH. Gilliet M, et al. Among authors: boehncke wh. Rev Med Suisse. 2022 Mar 30;18(775):571-572. doi: 10.53738/REVMED.2022.18.775.571. Rev Med Suisse. 2022. PMID: 35353451 French. No abstract available.
Parlons du prurit.
Boehncke WH, Gilliet M. Boehncke WH, et al. Rev Med Suisse. 2023 Mar 29;19(820):603-604. doi: 10.53738/REVMED.2023.19.820.603. Rev Med Suisse. 2023. PMID: 36988166 French. No abstract available.
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis.
Zabotti A, De Marco G, Gossec L, Baraliakos X, Aletaha D, Iagnocco A, Gisondi P, Balint PV, Bertheussen H, Boehncke WH, Damjanov NS, de Wit M, Errichetti E, Marzo-Ortega H, Protopopov M, Puig L, Queiro R, Ruscitti P, Savage L, Schett G, Siebert S, Stamm TA, Studenic P, Tinazzi I, Van den Bosch FE, van der Helm-van Mil A, Watad A, Smolen JS, McGonagle DG. Zabotti A, et al. Among authors: boehncke wh. Ann Rheum Dis. 2023 Sep;82(9):1162-1170. doi: 10.1136/ard-2023-224148. Epub 2023 Jun 9. Ann Rheum Dis. 2023. PMID: 37295926 Free article.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Nash P, Kerschbaumer A, Dörner T, Dougados M, Fleischmann RM, Geissler K, McInnes I, Pope JE, van der Heijde D, Stoffer-Marx M, Takeuchi T, Trauner M, Winthrop KL, de Wit M, Aletaha D, Baraliakos X, Boehncke WH, Emery P, Isaacs JD, Kremer J, Lee EB, Maksymowych WP, Voshaar M, Tam LS, Tanaka Y, van den Bosch F, Westhovens R, Xavier R, Smolen JS. Nash P, et al. Among authors: boehncke wh. Ann Rheum Dis. 2021 Jan;80(1):71-87. doi: 10.1136/annrheumdis-2020-218398. Epub 2020 Nov 6. Ann Rheum Dis. 2021. PMID: 33158881 Free PMC article.
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond.
Brembilla NC, Senra L, Boehncke WH. Brembilla NC, et al. Among authors: boehncke wh. Front Immunol. 2018 Aug 2;9:1682. doi: 10.3389/fimmu.2018.01682. eCollection 2018. Front Immunol. 2018. PMID: 30127781 Free PMC article. Review.
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Deodhar A, Helliwell PS, Boehncke WH, Kollmeier AP, Hsia EC, Subramanian RA, Xu XL, Sheng S, Agarwal P, Zhou B, Zhuang Y, Ritchlin CT; DISCOVER-1 Study Group. Deodhar A, et al. Among authors: boehncke wh. Lancet. 2020 Apr 4;395(10230):1115-1125. doi: 10.1016/S0140-6736(20)30265-8. Epub 2020 Mar 13. Lancet. 2020. PMID: 32178765 Free article. Clinical Trial.
Impact dermatologique du changement climatique.
Gilliet M, Boehncke WH. Gilliet M, et al. Among authors: boehncke wh. Rev Med Suisse. 2024 Mar 27;20(867):619-620. doi: 10.53738/REVMED.2024.20.867.619. Rev Med Suisse. 2024. PMID: 38563535 French. No abstract available.
376 results